News
05-06-2010, 06:40 AM
Abraxis BioScience, Inc., a fully integrated biotechnology company, today reported unaudited financial results for the first quarter ended March 31, 2010.
More... (http://www.news-medical.net/news/20100506/Abraxis-Bioscience-first-quarter-ABRAXANE-revenue-increases-to-24879-million.aspx)
More... (http://www.news-medical.net/news/20100506/Abraxis-Bioscience-first-quarter-ABRAXANE-revenue-increases-to-24879-million.aspx)